- Afamin — A pleiotropic glycoprotein involved in various disease states
- Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases
- PP.27.04: ENDOTHELIAL DYSFUNCTION AND ARTERIAL HYPERTENSION IN THE WORKING POPULATION (MERIDIAN STUDY).
- Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?
- Overexpression of the A-FABP gene facilitates intermuscular fat deposition in transgenic mice
- Early Complement Component Deficiency in a Single-Centre Cohort of Pediatric Onset Lupus
- Angptl4 is upregulated under inflammatory conditions in the bone marrow of mice, expands myeloid progenitors, and accelerates reconstitution of platelets after myelosuppressive therapy
- Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages
- Effect of Sleeve Gastrectomy Plus Side-to-Side Jejunoileal Anastomosis for Type 2 Diabetes Control in an Obese Rat Model
- Relation of Osteoprotegerin, Visfatin and Ghrelin to Metabolic Syndrome in Type 2 Diabetic Patients
- Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis
- Danhong injection protects cardiomyocytes against hypoxia/reoxygenation- and H2O2-induced injury by inhibiting mitochondrial permeability transition pore opening
- Host Defense Proteins in Breast Milk and Neonatal Yeast Colonization
- Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release
- Anti-Proliferative and Apoptotic Activities of Müllerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell Lines
- Serum IL-6 and IL-10 concentrations in bitches with pyometra undergoing ovariohysterectomy
- Salvia Miltiorrhiza Bge.f.alba Ameliorates the Progression of Monocrotaline-Induced Pulmonary Hypertension by Protecting Endothelial Injury in Rats
- Antioxidant resveratrol restores renal sodium transport regulation in SHR
- Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression
- Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance
